Abstract:An efficient synthesis method was developed for furoxan/1,2,4-triazole hybrids 5a-k from methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates 1 through two-steps reaction including hydrolyzation and esterification. All of the furoxan/1,2,4-triazole hybrid derivatives were characterized by spectroscopy. On the other hand, the influence of newly synthesized multi-substituted 1,2,4-triazoles on the exogenous NO release ability, in vitro and in vivo anti-inflammatory activity, and in silico predictions were experimentally evaluated. Based on the exogenous NO release ability study and SAR studies of in vitro anti-inflammatory activity, all of compounds 5a-k exhibited slightly NO release ability and potential anti-inflammatory activity on LPS-induced RAW264.7 cells (IC50 = 5.74-15.3 μM) compared to Celecoxib (IC50 = 16.5 μM) and Indomethacin (IC50 = 56.8 μM). Furthermore, compounds 5a-k were also subjected to in vitro COX-1/COX-2 inhibition assays. Particularly, compound 5f exhibited extraordinary COX-2 inhibition (IC50 = 0.0455 μM) and selectivity (SI = 209). In addition, compound 5f was also examined in vivo pro-inflammatory cytokine productions and gastric safety and possessed the better inhibition of cytokine and safety compared with Indomethacin at the same concentration. Through the molecular modeling and in silico physicochemical and pharmacokinetic properties prediction, compound 5f was stabilized in COX-2 active binding site and possessed the fundamental strong H-bond interaction with Arg499 to form the significant physicochemical and pharmacological properties as a candidate drug. Following the in vitro, in vivo, and in silico study results, compound 5f demonstrated to be a potential anti-inflammatory agent and had comparable effects with Celecoxib.

Synthesis of a Novel Antianginal Agent Ranolazine

The Synthetic Technology of Ranolazine

Synthesis of 4-(2-amino-1-hydroxy-ethyl)-phenol Hydrochloride

Synthesis of 6-Fluoro-3,4-dihydro-2h-1-benzopyran-2-carboxylic Acid

Improvement on Synthesis of 2-Chloromethyl-3,5-dimethyl-4-nitropyridine Hydrochloride

New Technical Synthesis of (R)-Rolipram

Diastereospecific epoxidation and highly regioselective ring-opening of (+)-valienamine: Practical synthesis of (+)-valiolamine

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease

Synthesis of the C1–C12 Acid Fragment of Amphidinolide T Marine Macrolides Via SmI2-mediated Enantioselective Reductive Coupling of Aldehydes with a Chiral Crotonate

Synthesis of New Antifungal Agents--triazole Propanol Derivatives Containing Nitrogen

One-Pot Total Synthesis of Natural Products Nitramarine, Nitraridine, and Analogues via a Cascade Oxidation/Pictet-Spengler Condensation/Annulation Process

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

First Total Synthesis Of Antihypertensive Natural Products S-(+)-Xjp And R-(-)-Xjp

Synthesis of 3,3-Disubstituted Oxindoles from N-Arylacrylamides and Unactivated Alkyl Bromides via Nickel-Catalyzed Cascade Cyclization and Their Inhibitory Effect on NO Release

Synthesis of (±)-N-acyl norepinephrine and its analogs

Total Synthesis of (−)-Amovillosumin A and Structure Correction of (−)-Amovillosumin C Using Chemical Synthesis

Synthesis and Antioxidant Activity of Novel Mannich Base of 1,3,4-Oxadiazole Derivatives Possessing 1,4-Benzodioxan.

Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer’s Disease

Synthesis and Bioactivities Evaluation of Novel Anthranilic Diamides Containing N ‐( tert ‐Butyl)benzohydrazide Moiety as Potent Ryanodine Receptor Activator

Synthesis and anti-inflammatory activity evaluation of NO-releasing furoxan/1,2,4-triazole hybrid derivatives